Parkside Financial Bank & Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.05K | Sell |
19
-79
| -81% | -$4.35K | ﹤0.01% | 2248 |
|
2025
Q1 | $6.93K | Buy |
98
+52
| +113% | +$3.68K | ﹤0.01% | 1534 |
|
2024
Q4 | $3.02K | Sell |
46
-66
| -59% | -$4.34K | ﹤0.01% | 1551 |
|
2024
Q3 | $7.87K | Sell |
112
-186
| -62% | -$13.1K | ﹤0.01% | 1318 |
|
2024
Q2 | $24.5K | Sell |
298
-53
| -15% | -$4.36K | ﹤0.01% | 965 |
|
2024
Q1 | $30.7K | Buy |
351
+240
| +216% | +$21K | ﹤0.01% | 905 |
|
2023
Q4 | $10.7K | Sell |
111
-162
| -59% | -$15.6K | ﹤0.01% | 1126 |
|
2023
Q3 | $24.2K | Sell |
273
-5
| -2% | -$442 | 0.01% | 845 |
|
2023
Q2 | $24.1K | Buy |
278
+175
| +170% | +$15.2K | 0.01% | 825 |
|
2023
Q1 | $10K | Sell |
103
-6
| -6% | -$583 | ﹤0.01% | 1104 |
|
2022
Q4 | $11.3K | Buy |
109
+26
| +31% | +$2.69K | ﹤0.01% | 1025 |
|
2022
Q3 | $7K | Hold |
83
| – | – | ﹤0.01% | 1080 |
|
2022
Q2 | $7K | Buy |
83
+10
| +14% | +$843 | ﹤0.01% | 1097 |
|
2022
Q1 | $6K | Sell |
73
-32
| -30% | -$2.63K | ﹤0.01% | 1197 |
|
2021
Q4 | $10K | Buy |
105
+7
| +7% | +$667 | ﹤0.01% | 1015 |
|
2021
Q3 | $7K | Buy |
98
+51
| +109% | +$3.64K | ﹤0.01% | 1068 |
|
2021
Q2 | $4K | Buy |
47
+10
| +27% | +$851 | ﹤0.01% | 1296 |
|
2021
Q1 | $3K | Hold |
37
| – | – | ﹤0.01% | 1350 |
|
2020
Q4 | $3K | Buy |
37
+34
| +1,133% | +$2.76K | ﹤0.01% | 1271 |
|
2020
Q3 | $0 | Sell |
3
-46
| -94% | – | ﹤0.01% | 1526 |
|
2020
Q2 | $6K | Buy |
+49
| New | +$6K | ﹤0.01% | 884 |
|
2019
Q1 | – | Sell |
-35
| Closed | -$3K | – | 1547 |
|
2018
Q4 | $3K | Sell |
35
-15
| -30% | -$1.29K | ﹤0.01% | 971 |
|
2018
Q3 | $5K | Hold |
50
| – | – | ﹤0.01% | 895 |
|
2018
Q2 | $5K | Hold |
50
| – | – | ﹤0.01% | 866 |
|
2018
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 890 |
|
2017
Q4 | $4K | Sell |
50
-34
| -40% | -$2.72K | ﹤0.01% | 885 |
|
2017
Q3 | $8K | Hold |
84
| – | – | ﹤0.01% | 770 |
|
2017
Q2 | $8K | Sell |
84
-121
| -59% | -$11.5K | ﹤0.01% | 774 |
|
2017
Q1 | $18K | Buy |
205
+1
| +0.5% | +$88 | 0.01% | 549 |
|
2016
Q4 | $17K | Sell |
204
-46
| -18% | -$3.83K | 0.01% | 569 |
|
2016
Q3 | $23K | Buy |
250
+119
| +91% | +$10.9K | 0.01% | 539 |
|
2016
Q2 | $10K | Sell |
131
-38
| -22% | -$2.9K | ﹤0.01% | 687 |
|
2016
Q1 | $14K | Buy |
169
+29
| +21% | +$2.4K | 0.01% | 586 |
|
2015
Q4 | $15K | Sell |
140
-27
| -16% | -$2.89K | 0.01% | 571 |
|
2015
Q3 | $18K | Buy |
+167
| New | +$18K | 0.01% | 506 |
|